216 related articles for article (PubMed ID: 33741507)
1. False amoxicillin/clavulanic acid susceptibility in Bacteroides fragilis using gradient strip tests.
Rentenaar RJ; Bovo-Heijmans B; Diggle J; Fluit AC; Wootton M
Anaerobe; 2021 Jun; 69():102358. PubMed ID: 33741507
[TBL] [Abstract][Full Text] [Related]
2. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
Nagy E; Justesen US; Eitel Z; Urbán E;
Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
[TBL] [Abstract][Full Text] [Related]
3. The in-vitro susceptibility of the Bacteroides fragilis group to amoxycillin-clavulanic acid.
Brown EM
J Antimicrob Chemother; 1984 Oct; 14(4):367-72. PubMed ID: 6501130
[TBL] [Abstract][Full Text] [Related]
4. A comparison of E. coli susceptibility for amoxicillin/clavulanic acid according to EUCAST and CLSI guidelines.
Vanstokstraeten R; Belasri N; Demuyser T; Crombé F; Barbé K; Piérard D
Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2371-2377. PubMed ID: 34175999
[TBL] [Abstract][Full Text] [Related]
5. A multicentre survey of the antibiotic susceptibility of clinical Bacteroides species from Hungary.
Sárvári KP; Sóki J; Kristóf K; Juhász E; Miszti C; Latkóczy K; Melegh SZ; Urbán E
Infect Dis (Lond); 2018 May; 50(5):372-380. PubMed ID: 29303023
[TBL] [Abstract][Full Text] [Related]
6. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
7. Emergence of carbapenem resistance in Bacteroides fragilis in China.
Gao Q; Wu S; Xu T; Zhao X; Huang H; Hu F
Int J Antimicrob Agents; 2019 Jun; 53(6):859-863. PubMed ID: 30831235
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait.
Jamal W; Khodakhast FB; AlAzmi A; Sόki J; AlHashem G; Rotimi VO
BMC Microbiol; 2020 Jan; 20(1):14. PubMed ID: 31941446
[TBL] [Abstract][Full Text] [Related]
9. [Can meropenem E-test be used to estimate the presence of carbapenem resistance gene cfiA among Bacteroides fragilis strains?].
Toprak Ülger N; Ilki A; Ozel N; Balkan N; Söyletir G
Mikrobiyol Bul; 2011 Jul; 45(3):385-91. PubMed ID: 21935771
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
Bourgault AM; Lamothe F
J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324
[TBL] [Abstract][Full Text] [Related]
11. Frequency and associated factors for carbapenem-non-susceptible Bacteroides fragilis group bacteria colonization in hospitalized patients: Case control study in a university hospital in Turkey.
Ulger Toprak N; Akgul O; Bilgin H; Ozaydin AN; Altinkanat Gelmez G; Sayin E; Sili U; Korten V; Soyletir G
Indian J Med Microbiol; 2021; 39(4):518-522. PubMed ID: 33812722
[TBL] [Abstract][Full Text] [Related]
12. Determinants of resistance in Bacteroides fragilis strains according to recent Brazilian profiles of antimicrobial susceptibility.
Paula GR; Falcão LS; Antunes EN; Avelar KE; Reis FN; Maluhy MA; Ferreira MC; Domingues RM
Int J Antimicrob Agents; 2004 Jul; 24(1):53-8. PubMed ID: 15225862
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of agar dilution and broth microdilution by commercial and in-house plates for Bacteroides fragilis group: An economical and expeditious approach for resource-limited settings.
Sood A; Angrup A; Ray P; Bala K
Anaerobe; 2021 Oct; 71():102443. PubMed ID: 34492368
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of amoxycillin and benzylpenicillin combined with clavulanic acid against Bacteroides fragilis in vitro and in experimentally infected mice.
Dijkmans BA; Vaishnav J; Mattie H
Scand J Infect Dis; 1985; 17(3):311-21. PubMed ID: 3903976
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of antimicrobial activity of amoxicillin/clavulanic acid and metronidazole against beta-lactamase-producing Bacteroides fragilis group.
García-Rodríguez JA; García Sánchez JE; Trujillano I; Muñoz-Bellido JL
J Chemother; 1990 Feb; 2(1):11-6. PubMed ID: 2332779
[TBL] [Abstract][Full Text] [Related]
16. Effect of amoxycillin/clavulanic acid (augmentin) against polymicrobial Bacteroides fragilis/Escherichia coli infections in the mouse.
Beale AS; Gisby J; Sutherland R
J Chemother; 1989 Jul; 1(4 Suppl):78-9. PubMed ID: 16312312
[No Abstract] [Full Text] [Related]
17. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
Appelbaum PC; Spangler SK; Jacobs MR
Antimicrob Agents Chemother; 1990 Aug; 34(8):1546-50. PubMed ID: 2221864
[TBL] [Abstract][Full Text] [Related]
18. Plasmid-related beta-lactamase production in Bacteroides fragilis strains.
Nakano V; Padilla G; do Valle Marques M; Avila-Campos MJ
Res Microbiol; 2004 Dec; 155(10):843-6. PubMed ID: 15567279
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacies of amoxicillin-clavulanic acid and ampicillin-sulbactam against experimental Bacteroides fragilis-Escherichia coli mixed infections.
Gisby J; Beale AS
Antimicrob Agents Chemother; 1988 Dec; 32(12):1830-3. PubMed ID: 3072924
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility profile of clinically relevant Bacteroides, Phocaeicola, Parabacteroides and Prevotella species, isolated by eight laboratories in the Netherlands.
Boiten KE; Notermans DW; Rentenaar RJ; van Prehn J; Bode LGM; Maat I; van der Zwet W; Jansz A; Siebers TJH; Rossen JWA; de Greeff SC; Hendrickx APA; Kuijper EJ; Veloo ACM
J Antimicrob Chemother; 2024 Apr; 79(4):868-874. PubMed ID: 38394460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
